INNATE PHARMA SA-SPONS ADR (IPHA) Earnings History & Surprises

NASDAQ:IPHA • US45781K2042

1.58 USD
-0.04 (-2.47%)
Last: Mar 5, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

Past quarterly earnings results for INNATE PHARMA SA-SPONS ADR (IPHA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateMar 26, 2026
PeriodQ3 / 2025
EPS Estimate-€0.11
Revenue Estimate1.98M

Last Reported

Most Recent
Release DateNov 13, 2025
PeriodQ2 / 2025
EPS Reported
EPS Surprise %
Revenue Surprise -65.96%

Beat Rate

Last 8 Quarters
0%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (EUR)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q2 2025 -0.23 - - 1.671M 4.909M -65.96% -79.85%
Q1 2025 -0.10 - - 4.868M - -
Q4 2024 - - 4.329M - -73.85%
Q2 2024 - - 8.293M - -76.54%
Q4 2023 - - 16.557M - 99.27%
Q2 2023 - - 35.344M - -14.36%
Q4 2022 - - 8.309M - 118.20%
Q2 2022 0.09 - - 41.271M - 397.00%
Q4 2021 -0.59 - -684.99% 3.808M - -85.53%
Q2 2021 - - 8.304M - -72.17%
Q4 2020 -0.07 - - 26.31M 27.379M -3.90% -
Q3 2020 -0.07 - - 27.379M - -
Q2 2020 - - 29.84M - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

IPHA EPS Q2Q GrowthIPHA EPS Q2Q GrowthEPS Q2Q Growth Q4/21 Q1/26 Q2/26 Q3/26 Q4/26 Q1/27 Q2/27 Q3/27 Q4/27 0 -200 -400 -600

Revenue Historical Q2Q growth and Acceleration

IPHA Revenue Q2Q GrowthIPHA Revenue Q2Q GrowthRevenue Q2Q Growth Q2/21 Q4/21 Q2/22 Q4/22 Q2/23 Q4/23 Q2/24 Q4/24 Q2/25 Q4/25 Q1/26 Q2/26 Q3/26 Q4/26 Q1/27 Q2/27 Q3/27 Q4/27 0 100 200 300

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

Related analysis

IPHA Overview IPHA Technical Analysis Report IPHA Fundamental Analysis Report IPHA Forecast & Price Target
 → Find peers who consistently beat earnings by at least 10% in the last 4 quarters

INNATE PHARMA SA-SPONS ADR / IPHA Earnings FAQ

When did INNATE PHARMA SA-SPONS ADR (IPHA) report earnings last quarter?

INNATE PHARMA SA-SPONS ADR (IPHA) last reported earnings on 11/13/2025.


Can you provide information on whether INNATE PHARMA SA-SPONS ADR beat earnings estimates in the last quarter?

INNATE PHARMA SA-SPONS ADR (IPHA) missed EPS estimates and missed revenue estimates in the most recent quarter.